| | Identification | Back Directory |  | [Name] 
 (3β)-3-[(4-Fluorobenzoyl)oxy]lup-20(29)-en-28-oic acid
 |  | [CAS] 
 1454575-38-2
 |  | [Synonyms] 
 ZM 522
 (3β)-3-[(4-Fluorobenzoyl)oxy]lup-20(29)-en-28-oic acid
 |  | [Molecular Formula] 
 C37H51FO4
 |  | [MOL File] 
 1454575-38-2.mol
 |  | [Molecular Weight] 
 578.8
 | 
 | Chemical Properties | Back Directory |  | [Boiling point ] 
 630.1±35.0 °C(Predicted)
 |  | [density ] 
 1.15±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
 |  | [solubility ] 
 DMF: 10 mg/ml
 DMSO: 2 mg/ml
 Ethanol: 2 mg/ml
 |  | [pka] 
 4.60±0.70(Predicted)
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 ZM522 is a CD73 inhibitor with an IC50 value of 0.56 μM. ZM522 effectively increases the levels of interferon-γ (INF-γ) and enhances immune activity by regulating the activation status of T cells. ZM522 holds promise for research in the fields of immunology and cancer therapy[1].
 |  | [References] 
 [1] Zhang Y, et al. Application of a fluorine strategy in the lead optimization of betulinic acid to the discovery of potent CD73 inhibitors. Steroids. 2022 Dec;188:109112. DOI:10.1016/j.steroids.2022.109112
 | 
 |  |